Commentary: Impact of Meningococcal Group B OMV Vaccines, Beyond Their Brief

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2017.1381810
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search